Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Joseph Miccio"'
Autor:
F. Jeffrey Lorenz, Sean S. Mahase, Joseph Miccio, Tonya S. King, Sandeep Pradhan, Neerav Goyal
Publikováno v:
Head & Neck.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1eec41a314504fab28d27d27c804bcc7
https://doi.org/10.1002/hed.27380
https://doi.org/10.1002/hed.27380
Autor:
Timil, Patel, Joseph, Miccio, Michael, Cecchini, Thejal, Srikumar, Stacey, Stein, Jeremy, Kortmanksy, Kimberly, Johung, Jill, Lacy
Publikováno v:
J Gastrointest Oncol
BACKGROUND: FOLFIRINOX (FFX) and gemcitabine plus nab-paclitaxel (GN) are established first line therapies for metastatic pancreatic cancer (MPC). There are, however, no randomized controlled trials comparing FFX and GN in the first line setting and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4fc114e94f7eb8ed1e500a022ac2b908
https://pubmed.ncbi.nlm.nih.gov/35070386
https://pubmed.ncbi.nlm.nih.gov/35070386
Autor:
Joseph, Miccio, Kimberly, Johung
Publikováno v:
Oncology (Williston Park, N.Y.). 33(5)
Historically, radiation therapy has played a limited role in the management of renal cell carcinoma because early studies showed that it had no benefit in the neoadjuvant or adjuvant settings. Thus, radiation has typically been employed for only pall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::99cd50d0f3a67b56818cbda32021a9a2
https://pubmed.ncbi.nlm.nih.gov/31095714
https://pubmed.ncbi.nlm.nih.gov/31095714